NHS England Adds Caveat to Palantir Benefit Claims

NHS England awarded a consortium led by Palantir Technologies a contract worth up to £330 million in November 2023 to build and operate the Federated Data Platform, which links data across hospitals to support elective care, discharges and cancer services. The project has become a test of whether large technology contracts can deliver measurable gains in a publicly funded health system while retaining trust over sensitive patient data. The strength of the evidence matters as ministers assess the contract and a potential break clause in 2027.

Following an investigation by the Office for Statistics Regulation in July 2026, NHS England added a caveat to its published benefits methodology and agreed that communications about the platform’s performance must be clearly and appropriately labelled. The health service said its comparisons cover the 12 months before adoption and the rolling 12 months after implementation, but cannot establish cause and effect because other variables were not controlled. Claims cited by Palantir and officials include more than 110,000 additional operations, a 15% reduction in discharge delays and a 6.8% increase in patients receiving a cancer result within 28 days.